Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
By Alex Ruoff
The House approved 25 bills meant to give public health officials new powers and make other changes to fight the opioid epidemic June 12.
Most of the measures were waived through the House unanimously and largely seek to create grant programs, new federal research, guidance, and reports on issues related to the opioid epidemic, which contributed to more than 64,000 overdose deaths in 2016. Lawmakers voted on two other bills later June 12: H.R. 5327, which would create a grant program to establish comprehensive opioid treatment centers, and H.R. 5041, which would let hospice employees dispose of people’s medications after they die.
“We have worked long and hard to help communities in despair,” Rep. Greg Walden (R-Ore.), chairman of the House Energy and Commerce Committee, said on the House floor.
The hospice bill, H.R. 5041, was approved unanimously, and the grant program measure passed 383-13.
One of the approved measures would call on the U.S. surgeon general to report to Congress on the effects of new psychoactive substances including synthetic drugs on children, while another would give the National Institutes of Health more flexibility to use its grant funding to research opioid alternatives.
The House is slated to take up more than a dozen other opioid bills later in the week and as many as 20 more the following week.
The more controversial measures, such as expanding Medicaid payments for some inpatient drug treatment services and allowing nurses to prescribe the addiction treatment drug buprenorphine, could come up for votes next week, Republican and Democratic staffers told Bloomberg Law June 12.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)